Skip to main content

Table 2 Clinicopathological features of the patients and correlation of SALL4 gene expression with them

From: Role of SALL4 in the progression and metastasis of colorectal cancer

Factor

Number (%)

SALL4

P value

↑

↓ / -

Tumor invasion

    

T1, T2

8 (17.4%)

8

0

0.538

T3, T4

38 (82.6%)

32

6

Lymph node metastasis

    

N0

33 (71.7%)

28

5

0.047*

N1

9 (19.6%)

9

0

N2

4 (8.7)

3

1

Stage

    

I/II

34 (73.9%)

29

5

0.397

III/IV

12 (26.1%)

11

1

Grade

    

WD

29 (63%)

25

4

0.020*

MD

16 (34.8%)

15

1

PD

1 (2.2%)

0

1

Tumor location

    

Proximal

13 (28.3%)

11

2

0.611

Distal

33 (71.7%)

29

4

Sex

    

Male

26 (56.5%)

22

4

0.030*

Female

20 (43.5%)

18

2

  1. WD: Well differentiated; MD: Moderately differentiated; PD: Poorly differentiated.
  2. *Significant correlation between SALL4 mRNA expression and clinicopathological feature.